Live Breaking News & Updates on Evh

Stay informed with the latest breaking news from Evh on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Evh and stay connected to the pulse of your community

Evolent Health, Inc. (NYSE:EVH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Evolent Health, Inc. (NYSE:EVH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price objective among […]

United-states , William-blair , Canaccord-genuity-group , Hedge-funds-weigh-in-on-evolent-health , Securities-inc , Group-wealth-management , Analyst-recommendations-for-evolent-health , Evolent-health , Evolent-health-stock-performance , Jpmorgan-chase-co , Evolent-health-inc , Tower-group

Canaccord Genuity Group Lowers Evolent Health (NYSE:EVH) Price Target to $44.00

Evolent Health (NYSE:EVH – Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a research report report published on Thursday, Benzinga reports. They currently have a buy rating on the technology company’s stock. A number of other equities analysts have also issued reports on the company. Oppenheimer assumed […]

United-states , Wellington , New-zealand-general- , New-zealand , William-blair , News-ratings-for-evolent-health-daily , Barclays , Bellevue-group , Jpmorgan-chase-co , Evolent-health , Institutional-trading-of-evolent-health , Evolent-health-inc

Canaccord Genuity Group Trims Evolent Health (NYSE:EVH) Target Price to $44.00

Evolent Health (NYSE:EVH – Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the technology company’s stock. Several other analysts have also commented on EVH. William Blair reiterated an outperform rating on shares […]

United-states , American , William-blair , Canaccord-genuity-group , Analyst-recommendations-for-evolent-health , Blackrock-inc , Evolent-health-price-performance , Metlife-investment-management , American-century-companies-inc , Evolent-health , Institutional-trading-of-evolent-health , Hightower-advisors

Evolent Health (NYSE:EVH) Price Target Cut to $45.00 by Analysts at Canaccord Genuity Group

Evolent Health (NYSE:EVH – Free Report) had its target price trimmed by Canaccord Genuity Group from $47.00 to $45.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the technology company’s stock. A number of other equities analysts also recently weighed in on EVH. […]

Wellington , New-zealand-general- , New-zealand , Canada , United-states , Blackrock , William-blair , Seth-blackley , Analyst-recommendations-for-evolent-health , Evolent-health-trading , Evolent-health-inc , Wellington-management-group

Evolent Health (NYSE:EVH) Shares Gap Up to $29.77

Evolent Health, Inc. (NYSE:EVH – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.77, but opened at $32.75. Evolent Health shares last traded at $31.81, with a volume of 258,344 shares trading hands. Wall Street Analyst Weigh In Several research firms recently weighed […]

United-states , American , Seth-blackley , William-blair , Evolent-health-inc , Evolent-health-company-profile , Blackrock-inc , Evolent-health-stock , News-ratings-for-evolent-health-daily , Vanguard-group-inc , Evolent-health-services , Metlife-investment-management

Evolent Health, Inc. (NYSE:EVH) Given Average Rating of "Moderate Buy" by Brokerages

Evolent Health, Inc. (NYSE:EVH – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year target […]

Canada , United-states , New-york , Seth-blackley , Daniel-joseph-mccarthy , Seacrest-wealth-management , News-ratings-for-evolent-health-daily , First-republic-investment-management-inc , Evolent-health , Clinical-solutions , Securities-exchange-commission , Insider-activity-at-evolent-health

Brokerages Set Evolent Health, Inc. (NYSE:EVH) Price Target at $41.25

Evolent Health, Inc. (NYSE:EVH – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month price […]

United-states , New-york , William-blair , Seth-blackley , Daniel-joseph-mccarthy , Seacrest-wealth-management , Evolent-health-company-profile , Evolent-health-services , Securities-exchange-commission , Institutional-trading-of-evolent-health , Clinical-solutions , Evolent-health

Evolent Health (NYSE:EVH) Stock Rating Reaffirmed by William Blair

William Blair reiterated their outperform rating on shares of Evolent Health (NYSE:EVH – Free Report) in a report issued on Tuesday, RTT News reports. A number of other brokerages have also weighed in on EVH. StockNews.com upgraded Evolent Health to a sell rating in a report on Monday, October 16th. JMP Securities started coverage on […]

Canada , United-states , William-blair , Seth-blackley , Daniel-joseph-mccarthy , Evolent-health , Barclays , News-ratings-for-evolent-health-daily , Clinical-solutions , Hedge-funds-weigh-in-on-evolent-health , Evolent-health-company-profile , Nisa-investment-advisors

Evolent Health (NYSE:EVH) Now Covered by Analysts at Barclays

Barclays started coverage on shares of Evolent Health (NYSE:EVH – Free Report) in a research report released on Wednesday, Briefing.com reports. The firm issued an overweight rating and a $39.00 price target on the technology company’s stock. Other equities research analysts have also issued reports about the stock. Truist Financial decreased their target price on […]

United-states , Wellington , New-zealand-general- , New-zealand , Daniel-joseph-mccarthy , Seth-blackley , Evolent-health-services , Evolent-health-inc , Wellington-management-group , Evolent-health , News-ratings-for-evolent-health-daily , Evolent-health-price-performance

Evolent Health (NYSE:EVH) PT Lowered to $42.00 at Royal Bank of Canada

Evolent Health (NYSE:EVH – Free Report) had its price target cut by Royal Bank of Canada from $44.00 to $42.00 in a research note published on Tuesday morning, Benzinga reports. They currently have an outperform rating on the technology company’s stock. Other equities research analysts have also recently issued reports about the company. Truist Financial […]

Canada , United-states , Daniel-joseph-mccarthy , Evolent-health-services , Group-wealth-management , Royal-bank , Tower-research-capital , Analyst-recommendations-for-evolent-health , Evolent-health-stock-performance , Clinical-solutions , Hedge-funds-weigh-in-on-evolent-health , Tower-group